Globus Medical (GMED) Invested Capital (2020 - 2024)

Globus Medical's (GMED) quarterly Invested Capital came in at $443.4 million in Q4 2024, up 1.42% on a QoQ basis from $437.1 million in Q3 2024.

Globus Medical (GMED) Invested Capital (2020 - 2024) Analysis & Trends

Globus Medical (GMED) has 2 years of Invested Capital data on file, last reported at $443.4 million in Q4 2024.

Quarterly Invested Capital changed N/A year-over-year to $443.4 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $443.4 million (down 65.68% YoY) and the FY2024 annual result came in at $443.4 million, changed N/A from the prior year.
Invested Capital improved to $443.4 million in Q4 2024, from $437.1 million in the prior quarter.
In the past five years, Invested Capital ranged from a high of $443.4 million in Q4 2024 to a low of $10.0 million in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	3.01 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	750.00 Mn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	1.71 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	-
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	2.00 Mn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	1.34 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	243.40 Mn
10	Globus Medical	11.59 Bn	10.99 Bn	548.17 Mn	-

Download Data